May 29, 2019Open Access
达拉图单抗联合来那度胺和地塞米松治疗未经治疗的多发性骨髓瘤
Key Points
Key points are not available for this paper at this time.
Abstract
在不适合自体干细胞移植的新诊断多发性骨髓瘤患者中，接受达拉图单抗联合来那度胺和地塞米松治疗的患者，其疾病进展或死亡的风险显著低于仅接受来那度胺和地塞米松治疗的患者。达拉图单抗组观察到中性粒细胞减少症和肺炎的发生率较高。（资助单位：杨森研发；MAIA 临床试验注册号NCT02252172。）
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...
Authors
Thierry Façon
Roswell Park Comprehensive Cancer Center
Shaji Kumar
Mayo Clinic
T
Torben Plesner
University of Southern Denmark
Journals
New England Journal of Medicine
Actions
Institutions
Massachusetts General Hospital
Inserm
The University of Melbourne
References and Citations
Connected Papers
Building similarity graph...
Analyzing shared references across papers
Discussion
Loading...